Ebastine

Chemical formula: C₃₂H₃₉NO₂  Molecular mass: 469.658 g/mol  PubChem compound: 3191

Therapeutic indications

Ebastine is indicated for:

Allergic rhinitis (seasonal and perennial)

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Allergic rhinitis (seasonal and perennial) whether or not associated with allergic conjunctivitis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Idiopathic chronic urticaria

Population group: only adults (18 years old or older)

Chronic idiopathic urticaria

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Allergic dermatitis

Population group: only adults (18 - 65 years old)

Atopic dermatitis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) : EBASTINE Oral orodispersible tablet
Summary of Product Characteristics (SPC) 2020: EBASTEL Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈